One Ascent Wealth Management LLC United Therapeutics Corp Transaction History

One Ascent Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$205.95 - $280.43 $85,263 - $116,098	-414 Reduced 35.57%	750 $209,000
Q3 2022 Nov 02, 2022	SELL	$203.3 - $244.17 $5,895 - $7,080	-29 Reduced 2.43%	1,164 $244,000
Q2 2022 Aug 08, 2022	BUY	$174.81 - $241.14 $3,845 - $5,305	22 Added 1.88%	1,193 $281,000
Q1 2022 May 12, 2022	BUY	$166.16 - $213.96 $194,573 - $250,547	1,171 New	1,171 $210,000
Q4 2021 Feb 08, 2022	SELL	$184.32 - $216.08 $357,396 - $418,979	-1,939 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $348,748 - $416,652	1,939 New	1,939 $358,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Wealth Management LLC with notifications on news.